Gastroparesis and Functional Dyspepsia: A Blurring Distinction of Pathophysiology and Treatment

Gastroparesis and functional dyspepsia are 2 of the most common gastric neuromuscular disorders. These disorders are usually confused, having both similarities and differences. The pathophysiology of these disorders involves abnormal gastric motility, visceral hypersensitivity, mucosal inflammation, and various cellular changes. Both disorders have similar symptoms such as epigastric pain or discomfort, early satiety, and bloating. If patients suspected of having either gastroparesis or functional dyspepsia present with upper gastrointestinal symptoms, they should undergo upper endoscopy to exclude an alternative organic cause. Although the gastric emptying rate is frequently assessed during the clinical workup of patients with gastroparesis or functional dyspepsia, the correlation between gastric emptying and the symptoms is generally poor. Once the diagnosis of gastroparesis or functional dyspepsia is made, treatment should focus on the predominant symptom. Recently, various treatment modalities have been developed and validated. Prokinetic agents are generally used as treatment for both gastroparesis and functional dyspepsia. Acid-suppressive therapy, Helicobacter pylori eradication, and use of drugs that enhance gastric accommodation are employed for functional dyspepsia. Psychoactive drugs are also effective in symptom control. For gastroparesis, antiemetic agents, ghrelin receptor agonists, and serotonergic agents are used aside from prokinetic agents. Acupuncture and gastric electrical stimulation can be attempted. In severe cases, endoscopic and surgical interventions are considered for symptom control.

[1]  G. Wilding,et al.  Small bowel fed response as measured by wireless motility capsule: Comparative analysis in healthy, gastroparetic, and constipated subjects , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[2]  P. Enck,et al.  The Diagnosis and Treatment of Functional Dyspepsia. , 2018, Deutsches Arzteblatt international.

[3]  A. Zinsmeister,et al.  Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia , 2018, The American Journal of Gastroenterology.

[4]  W. Richardson,et al.  Tailored approach to gastroparesis significantly improves symptoms , 2018, Surgical Endoscopy.

[5]  Sumio Watanabe,et al.  A Systematic Review of the Effectiveness of Antianxiety and Antidepressive Agents for Functional Dyspepsia , 2017, Internal medicine.

[6]  B. Lacy,et al.  Gastroparesis: Medical and Therapeutic Advances , 2017, Digestive Diseases and Sciences.

[7]  D. J. Kim,et al.  Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis , 2017, BMC Gastroenterology.

[8]  T. Abell,et al.  Gastroparesis Updates on Pathogenesis and Management , 2017, Gut and liver.

[9]  P. Pasricha,et al.  Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing , 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[10]  Bo Pang,et al.  Acupuncture for Functional Dyspepsia: What Strength Does It Have? A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2016, Evidence-based complementary and alternative medicine : eCAM.

[11]  kimjuyeon,et al.  Individualized Acupuncture for Symptom Relief in Functional Dyspepsia: A Randomized Controlled Trial , 2016 .

[12]  K. Tominaga,et al.  Concentration of Glial Cell Line-Derived Neurotrophic Factor Positively Correlates with Symptoms in Functional Dyspepsia , 2016, Digestive Diseases and Sciences.

[13]  Yunxian Yu,et al.  Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study , 2016, Scientific Reports.

[14]  M. Camilleri Functional Dyspepsia and Gastroparesis , 2016, Digestive Diseases.

[15]  Xuezhu Zhang,et al.  The Short-Term Effects of Acupuncture on Patients with Diabetic Gastroparesis: A Randomised Crossover Study , 2015, Acupuncture in medicine : journal of the British Medical Acupuncture Society.

[16]  B. Matellanes,et al.  A randomized controlled trial of a 10 week group psychotherapeutic treatment added to standard medical treatment in patients with functional dyspepsia. , 2015, Journal of psychosomatic research.

[17]  M. Camilleri,et al.  Prokinetics in gastroparesis. , 2015, Gastroenterology clinics of North America.

[18]  B. Lacy,et al.  Treatment of Functional Dyspepsia and Gastroparesis , 2014, Current Treatment Options in Gastroenterology.

[19]  E. Ben-Arye,et al.  Benefits of Acupuncture for Diabetic Gastroparesis: A Comparative Preliminary Study , 2014, Acupuncture in medicine : journal of the British Medical Acupuncture Society.

[20]  M. Camilleri,et al.  Simplifying the measurement of gastric accommodation using SPECT , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[21]  M. Faramarzi,et al.  A randomized controlled trial of brief psychoanalytic psychotherapy in patients with functional dyspepsia. , 2013, Asian journal of psychiatry.

[22]  T. Abell,et al.  Gastric Electrical Stimulation for Abdominal Pain in Patients with Symptoms of Gastroparesis , 2013, The American surgeon.

[23]  J. Tack,et al.  Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia , 2013, Gut.

[24]  B. Lacy Functional Dyspepsia and Gastroparesis: One Disease or Two? , 2012, The American Journal of Gastroenterology.

[25]  J. Tack,et al.  Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[26]  Daphne Ang Measurement of gastric accommodation: a reappraisal of conventional and emerging modalities , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[27]  M. Camilleri,et al.  New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders , 2010, Expert opinion on investigational drugs.

[28]  R. Brun,et al.  Review: Functional dyspepsia , 2010, Therapeutic advances in gastroenterology.

[29]  L. Marciani,et al.  Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[30]  J. Tack Gastric motor and sensory function , 2009, Current opinion in gastroenterology.

[31]  R. Bisschops,et al.  Relationship between symptom pattern, assessed by the PAGI‐SYM© questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[32]  Z. Lin,et al.  Association of the status of interstitial cells of Cajal and electrogastrogram parameters, gastric emptying and symptoms in patients with gastroparesis , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[33]  R. Lane,et al.  Brain imaging approaches to the study of functional GI disorders: A Rome Working Team Report , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[34]  J. Vandenberghe,et al.  Influence of abuse history on gastric sensorimotor function in functional dyspepsia , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[35]  J. Tack,et al.  Influence of buspirone on gastric sensorimotor function in man , 2008, Alimentary pharmacology & therapeutics.

[36]  J. Tack,et al.  Acotiamide hydrochloride (Z‐338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[37]  J. Vandenberghe,et al.  Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation? , 2008, Gut.

[38]  K. Verbeke,et al.  Relationship between symptoms and ingestion of a meal in functional dyspepsia , 2008, Gut.

[39]  J. Tack,et al.  Pathogenesis of Dyspepsia , 2008, Digestive Diseases.

[40]  J. Studts,et al.  A Novel Classification Scheme for Gastroparesis Based on Predominant-Symptom Presentation , 2008, Journal of clinical gastroenterology.

[41]  J. Shaw,et al.  The in vitro pharmacological profile of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity , 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.

[42]  B. Coulie,et al.  Reproducibility and symptomatic predictors of a slow nutrient drinking test in health and in functional dyspepsia , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[43]  J. Schuurkes,et al.  5‐HT4 receptor agonists: similar but not the same , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[44]  W. Chey,et al.  Comparison of gastric emptying of a nondigestible capsule to a radio‐labelled meal in healthy and gastroparetic subjects , 2007, Alimentary pharmacology & therapeutics.

[45]  B. Spiegel,et al.  Functional GI disorders: from animal models to drug development , 2007, Gut.

[46]  J. Tack,et al.  An audit of technical pitfalls of gastric barostat testing in dyspepsia , 2007, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[47]  J. Matiasek,et al.  Hypersensitivity for capsaicin in patients with functional dyspepsia , 2007, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[48]  N. Talley,et al.  Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? , 2007, Alimentary pharmacology & therapeutics.

[49]  J. Tack,et al.  Impaired gastric accommodation and its role in dyspepsia , 2006, Gut.

[50]  G. Karamanolis,et al.  Determinants of symptom pattern in idiopathic severely delayed gastric emptying: gastric emptying rate or proximal stomach dysfunction? , 2006, Gut.

[51]  K. Gwee,et al.  Functional dyspepsia and irritable bowel syndrome, are they different entities and does it matter? , 2006, World journal of gastroenterology.

[52]  R. Bisschops,et al.  Influence of ghrelin on gastric emptying and meal‐related symptoms in idiopathic gastroparesis , 2005, Alimentary pharmacology & therapeutics.

[53]  M. Kamm,et al.  Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study , 2005, Gut.

[54]  袁孟彪,et al.  Functional dyspepsia , 2005 .

[55]  B. Geypens,et al.  Symptoms Associated With Impaired Gastric Emptying of Solids and Liquids in Functional Dyspepsia , 2003, American Journal of Gastroenterology.

[56]  P D Klein,et al.  Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying , 2001, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[57]  A. Zinsmeister,et al.  Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. , 2001, Gastroenterology.

[58]  P. Pasricha,et al.  The treatment of diabetic gastroparesis with botulinum toxin , 2000, American Journal of Gastroenterology.

[59]  J. Tack,et al.  Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria , 2017, The American Journal of Gastroenterology.

[60]  N. Talley,et al.  Functional dyspepsia. , 2017, Australian prescriber.

[61]  F. Chan,et al.  Rome IV - Gastroduodenal Disorders. , 2016, Gastroenterology.

[62]  H. Parkman Idiopathic gastroparesis. , 2015, Gastroenterology clinics of North America.

[63]  M. Camilleri,et al.  Clinical Guideline: Management of Gastroparesis , 2013, The American Journal of Gastroenterology.